Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11663739 | 0.73 | LMNA (0.31) | LMNA | |
| SCHEMBL3012794 | 0.72 | — | — | |
| SCHEMBL29209964 | 0.71 | LMNA (0.36) | LMNA | |
| SCHEMBL524697 | 0.71 | LMNA (0.36) | LMNA | |
| SCHEMBL29209906 | 0.71 | LMNA (0.36) | LMNA | |
| SCHEMBL3025862 | 0.69 | — | — | |
| SCHEMBL25905861 | 0.68 | GLI1 (0.35) | — | |
| SCHEMBL11360762 | 0.68 | GLI1 (0.35) | — | |
| SCHEMBL3019242 | 0.68 | — | — | |
| SCHEMBL3023176 | 0.67 | LMNA (0.31) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3112338-A2 | CYCLOHEXENE DERIVATIVES AND THEIR USE AS ODORANTS | Givaudan SA (CH) | 2017-01-04 | — | — | EP | claimed |
| US-8691746-B2 | Cyclohexene derivatives and their use as odorants | GIVAUDAN SA (CH) | 2014-04-08 | — | — | US | claimed |
| US-8304380-B2 | Cyclohexene derivatives and their use as odorants | GIVAUDAN SA (CH) | 2012-11-06 | — | — | US | claimed |
| EP-3112338-B1 | CYCLOHEXENE DERIVATIVES AND THEIR USE AS ODORANTS | GIVAUDAN SA (CH) | 2021-09-29 | — | — | EP | disclosed |
| EP-3112338-A2 | CYCLOHEXENE DERIVATIVES AND THEIR USE AS ODORANTS | Givaudan SA (CH) | 2017-01-04 | — | — | EP | disclosed |
| US-8691746-B2 | Cyclohexene derivatives and their use as odorants | GIVAUDAN SA (CH) | 2014-04-08 | — | — | US | disclosed |
| US-20130035278-A1 | Cyclohexene Derivatives and Their Use as Odorants | GIVAUDAN SA (CH) | 2013-02-07 | — | — | US | disclosed |
| US-8304380-B2 | Cyclohexene derivatives and their use as odorants | GIVAUDAN SA (CH) | 2012-11-06 | — | — | US | disclosed |
| US-20100204084-A1 | Cyclohexene Derivatives and Their Use as Odorants | GIVAUDAN SA (CH) | 2010-08-12 | — | — | US | disclosed |
| EP-2188242-A2 | CYCLOHEXENE DERIVATIVES AND THEIR USE AS ODORANTS | Givaudan SA (CH) | 2010-05-26 | — | — | EP | disclosed |
| WO-2009021342-A2 | CYCLOHEXENE DERIVATIVES AND THEIR USE AS ODORANTS | GIVAUDAN SA (CH) | 2009-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035278-A1 | Cyclohexene Derivatives and Their Use as Odorants | ESD, DHPS, BBOX1 | LMNA 951/4885 |
| US-20100204084-A1 | Cyclohexene Derivatives and Their Use as Odorants | ESD, DHPS, BBOX1 | LMNA 951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.